A Peptide You Inhale — Could This Change How We Treat Lung Disease?
Topic: Kither Biotech’s KIT2014 inhaled peptide completes Phase I trial (June 2026) If you or someone you love has COPD, cystic fibrosis, or chronic bronchitis, you know that current treatments are limited. Inhalers help open airways. Steroids reduce inflammation. But…
